| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_034bfd56a60f64c13aedf7b0e71dead6 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-00 |
| filingDate |
2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_045b1ed7de3d7fe586e8bf4ed2008cbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25136422e673512dcf25e3052bcec711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75239f2da448af86add415504e361ad9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3131bf4aae74e2ff0bb05274b78b964e |
| publicationDate |
2013-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2013204448-A1 |
| titleOfInvention |
Cylodextrin complexation methods for formulating peptide proteasome inhibitors |
| abstract |
This disclosure provides methods for formulating compositions comprising one or more peptide proteasome inhibitors and a cyclodextrin, particularly a substituted cyclodextrin. Such methods substantially increase the solubility and stability of these 5 proteasome inhibitors and facilitate both their manufacture and administration. |
| priorityDate |
2012-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |